Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,092
in 3 filings, $19K under 10b5-1 plans

Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. O'Neill Gilmore Neil −$16K CEO sold 2% of stake
  2. Burkly Linda −$2K EVP, CHIEF SCIENTIFIC OFFICER sold 1% of stake
  3. Parison Amy −$1K SVP, Chief Financial Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-07 Albright Charles EVP/Chief Scientific Officer Option exercise · Stock Option (right to buy) −20,000 165,000
2020-11-09 Michaels Lisa Anne EVP/Chief Medical Officer Grant or award +20,000 20,000
2020-11-09 Michaels Lisa Anne EVP/Chief Medical Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2020-11-09 Albright Charles EVP/Chief Scientific Officer Sale −228 $31.21 $7K 24,907
2020-10-15 Albright Charles EVP/Chief Scientific Officer Sale −3,000 $31.39 $94K 25,135
2020-08-20 Collins Cynthia CEO Sale −1,976 $36.66 $72K 45,022
2020-08-17 Albright Charles EVP/Chief Scientific Officer Option exercise +10,000 $16.51 $165K 38,135
2020-08-17 Albright Charles EVP/Chief Scientific Officer Sale −10,000 $35.29 $353K 28,135
2020-08-17 Albright Charles EVP/Chief Scientific Officer Option exercise · Stock Option (right to buy) −10,000 185,000
2020-08-07 Albright Charles EVP/Chief Scientific Officer Sale −238 $34.99 $8K 28,135
2020-08-06 Albright Charles EVP/Chief Scientific Officer Option exercise +10,000 $16.51 $165K 38,373
2020-08-06 Albright Charles EVP/Chief Scientific Officer Sale −10,000 $37.47 $375K 28,373
2020-08-06 Albright Charles EVP/Chief Scientific Officer Option exercise · Stock Option (right to buy) −10,000 195,000
2020-07-15 Albright Charles EVP/Chief Scientific Officer Sale −3,000 $32.22 $97K 28,373
2020-06-10 MULLEN JAMES C Director Grant or award · Stock Option (right to buy) +11,538 11,538
2020-06-10 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +11,538 11,538
2020-06-10 Hirsch Andrew Director Grant or award · Stock Option (right to buy) +11,538 11,538
2020-06-10 Vaishnaw Akshay Director Grant or award · Stock Option (right to buy) +11,538 11,538
2020-06-10 Scadden David Director Grant or award · Stock Option (right to buy) +11,538 11,538
2020-05-06 Albright Charles EVP/Chief Scientific Officer Sale −151 $25.28 $4K 31,373

Page 11 of 15 · 283 trades